Andrew Vernon

Statistics

Publications

Citations

1.6K

H-Index

Active since

1992

Affiliations

Centers for Disease Control and Prevention(Current)

Sorbonne Université

Denver Health Medical Center

University of Colorado Denver

Andrew Vernon is an author at Centers for Disease Control and Prevention specializing in tuberculosis control, pharmacotherapy, and tuberculosis pharmacotherapy.

Publications per year

1992–2010

Publications

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Debra Benator, Mondira Bhattacharya, Lorna Bozeman et al. · The Lancet · 2002 · 411 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

Eric L. Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 317 citations

Medicine, Pharmacology, Pharmacotherapy +14

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid

Andrew Vernon, William J. Burman, Debra Benator et al. · The Lancet · 1999 · 310 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial

Awal Khan, Timothy R. Sterling, Randall Reves et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 188 citations

Pharmacy, Pharmacotherapy, Tuberculosis Control +6

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

John L. Johnson, Alphonse Okwera, David L. Hom et al. · AIDS · 2001 · 154 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

1–5 of 10